Results summary | View all lists in GO:BiolProc | View all genes in C07AA.profile.d50 |
The specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. enrichment: 2.46-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
211143_X_AT | NR4A1 | G | R | S | nuclear receptor subfamily 4, group A, member 1 | ||||||||
200680_X_AT | HMGB1 | G | X | R | S | high-mobility group box 1 | |||||||
204421_S_AT | FGF2 | G | D | P | C | S | fibroblast growth factor 2 (basic) | ||||||
217607_X_AT | EIF4G2 | P | eukaryotic translation initiation factor 4 gamma, 2 | ||||||||||
221691_X_AT | NPM1 | G | T | X | R | S | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | ||||||
211943_X_AT | TPT1 | G | T | tumor protein, translationally-controlled 1 | |||||||||
209812_X_AT | CASP2 | G | P | S | caspase 2, apoptosis-related cysteine peptidase (neural precursor cell expressed, developmentally down-regulated 2) |